Patent details

Basic Information

Publication number:

EP3444281

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181832080

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMPROVED PEPTIDE PHARMACEUTICALS

French Title of Invention:

PRODUITS PHARMACEUTIQUES DE PEPTIDES AMÉLIORÉS

German Title of Invention:

VERBESSERTE PEPTIDARZNEIMITTEL

SPC Number:

Dates

Filing date:

20/11/2013

Grant date:

03/11/2021

EP Publication Date:

20/02/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/11/2021

EP B1 Publication Date:

03/11/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/11/2021

Expiration date:

20/11/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/10/2021

 

 

Name:

Eumederis Pharmaceuticals, Inc.

Address:

12707 High Bluff Drive, Suite 200, San Diego, CA 92130, United States (US)

Inventor

Name:

NESTOR, John, J

Address:

United States (US)

Priority

Priority Number:

201261728667 P

Priority Date:

20/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

C07K 19/00; C07K 7/06; A61K 38/08; C07K 1/107; A61K 38/00; A61K 38/07; A61K 38/26; A61K 38/29; C09D 101/28; C07K 5/065;

Publication

European Patent Bulletin

1

Issue number:

202144

Publication date:

03/11/2021

Description:

Grant (B1)

2

Issue number:

202149

Publication date:

08/12/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages